Screener
Pacira BioSciences, Inc. PCRX Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Cash and cash equivalents | $144,306 | $158,545 |
| Short-term available-for-sale investments | 57,874 | 79,879 |
| Accounts receivable, net | 125,635 | 124,069 |
| Inventories, net | 150,370 | 152,863 |
| Prepaid expenses and other current assets | 36,776 | 32,618 |
| Total current assets | 514,961 | 547,974 |
| Fixed assets, net | 136,281 | 140,690 |
| Right-of-use assets, net | 39,409 | 41,777 |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Pacira BioSciences, Inc.'s inventories?
- Pacira BioSciences, Inc. (PCRX) reported inventories of $150.37M in Q1 2026.
- How has Pacira BioSciences, Inc.'s inventories changed year-over-year?
- Pacira BioSciences, Inc.'s inventories increased by 12.4% year-over-year, from $133.75M to $150.37M.
- What is the long-term trend for Pacira BioSciences, Inc.'s inventories?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s inventories has grown at a 18.8% compound annual growth rate (CAGR), from $64.65M to $152.86M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Pacira BioSciences, Inc.'s inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude